Zealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared Holz

February 26, 2024
Zealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared HolzZealand’s obesity drug shouldn’t disrupt Novo Nordisk-Eli Lilly leadership: Mizuho’s Jared Holz
Share This

Jared Holz, Mizuho Americas, joins ‘Fast Money’ to talk obesity drugmakers after a new study out of Zealand Pharma analyzed the impact of GLP-1s on liver disease.

Latest Mizuho News

See all news
Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

Mizuho Expands “A Name Worth Knowing Award” to Support Two Promising Junior Golfers

May 8, 2026
Head of Investment and Corporate Banking Michal Katz on Bloomberg The Close (Starts at 1:15)

Head of Investment and Corporate Banking Michal Katz on Bloomberg The Close (Starts at 1:15)

April 29, 2026
All eyes on Coinbase after Robinhood's crypto revenue falls 47%

All eyes on Coinbase after Robinhood's crypto revenue falls 47%

May 5, 2026

Mizuho news from around the globe

 Mizuho Global News
back-to-top-blue